Clinical Trial Update: HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

View source ↗

Summary

Clinical trial update evaluating hepatic arterial infusion chemotherapy with lenvatinib and a PD-1 inhibitor for advanced hepatocellular carcinoma with macrovas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• PD-1 inhibitor

Snippet

Sponsor: Peking University | Conditions: Hepatocellular Carcinoma (HCC) | Status: NOT_YET_RECRUITING